THERALASE® TECHNOLOGIES
Stock Information
Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the
- TSX Venture Exchange (TLT: TSXV)
- TLTFF: OTCQB
Data last updated on June 4, 2024
Number of common shares outstanding
Shares Outstanding: 239,295,306
Warrants: 91,362,631
Stock Options: 18,500,000
For Investor Relations please contact: Investor Information Theralase®
Our Partners
As part of our continuing mission to design, develop, and manufacture cutting-edge laser technologies, Theralase® has partnered with individuals and groups at the following institutions and organizations.
